Endocrine Abstracts

Background: Response to therapy with glucose-lowering agents, in terms of glycemic control and weight loss, presents significant interindividual variability. This study investigated the association between clinical and laboratory parameters and response to therapy with sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus (T2DM).Methods: We retrospectively analyzed the medical records of people with T2DM in whom SGL...